AUSNUTRIA (01717) Reports Interim Results with Shareholders' Profit of RMB 180 Million, Up 24.12% YoY

Stock News
08/27

AUSNUTRIA (01717) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of RMB 3.887 billion, representing a year-on-year increase of 5.6%. Profit attributable to equity holders reached RMB 180 million, up 24.12% compared to the same period last year. Earnings per share stood at 10.14 cents.

Following two years of strategic adjustments and business optimization, the group has maintained steady revenue growth momentum. During the first half of 2025, total revenue reached RMB 3.887 billion, an increase of RMB 206 million or 5.6% from RMB 3.681 billion in the corresponding period of 2024.

The growth was primarily driven by exceptional performance in overseas markets for the group's proprietary goat milk formula products ("proprietary goat milk powder" or "Kabrita"), which surged 65.7% year-on-year, once again exceeding market expectations. Additionally, in October 2024, the group completed the strategic acquisition of the remaining 50% stake in Dutch goat cheese company Amalthea Group B.V. (Amalthea). This significant strategic move not only achieved autonomous control over core raw materials for Kabrita products but also enriched the group's business portfolio through the addition of cheese product lines, injecting new momentum into revenue growth. Furthermore, breakthroughs in the nutrition business also contributed to first-half revenue growth.

Regarding costs and expenses, during the first half of 2025, while striving for strong performance, the group focused on business refinement and implemented multiple cost control measures. Despite facing multiple pressures including rising milk prices and euro appreciation, the group continued to enhance supply chain efficiency, achieving effective cost management.

As of the first half of 2025, the group recorded profit attributable to equity holders of RMB 180 million, representing a 24.1% rebound compared to the same period in 2024.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10